“…6 Therefore, there is a need to collate CPGs in common dermatological diseases available internationally. 7 Firstly, this may help reduce research waste and identify high-quality CPGs and systematic reviews for future guideline development groups (GDGs) to reference from, avoiding duplication of work. Secondly, it will provide patients and clinicians with a summary of critically appraised dermatology CPGs, also highlighting areas for improvement in CPG reporting and development standards.…”